The newly approved velpatasvir/sofosbuvir regimen makes hepatitis C virus treatment simpler, but how much does it cost? Find the answer in
HIV and ID Observations.
The recently approved velpatasvir/sofosbuvir once-daily pill cured HCV in 95% to 99% of those treated. In the latest HIV and ID Observations blog post, Dr. Paul Sax explains the “potentially” good news about the new treatment's cost.